Genentech Launches Oncology Clinical Trial Diversity Alliance
Genentech
PR-M06-21-031Jun 24, 2021
Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia
Genentech
PA1285Sep 18, 2020
FDA
FDA Accepts Application for Xolair Prefilled Syringe for Self-Administration Across All Indications
Genentech
PR-M08-20-NI-32Aug 19, 2020
Influenza
Genentech’s Xofluza Flu Treatment Effective in Children
Emilie Branch
Pharma's Almanac
PAO-M07-19-NI-019Jul 22, 2019
FDA Approval
Genetech’s Antibody–Drug Conjugate Receives FDA Approval
Pharma's Almanac
PAO-M06-19-NI-010Jun 20, 2019
FDA Approval
FDA Approves Venetoclax for CLL and SLL
U.S. Food & Drug Administration
PR-M05-19-NI-057May 20, 2019
FDA Approval
Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia
Genentech
PR-M05-19-NI-050May 17, 2019
Clinical Data
New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
Genentech
PR-M04-18-NI-88Apr 25, 2018